United Capital Financial Advisers, LLC Royalty Pharma PLC Transaction History

United Capital Financial Advisers, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $1.49 Million - $1.68 Million	38,103 Added 105.05%	74,376 $2.94 Million
Q3 2022 Nov 14, 2022	SELL	$39.88 - $44.65 $155,212 - $173,777	-3,892 Reduced 9.69%	36,273 $1.46 Million
Q2 2022 Aug 11, 2022	BUY	$37.53 - $44.22 $1.51 Million - $1.78 Million	40,165 New	40,165 $1.69 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on United Capital Financial Advisers, LLC with notifications on news.